News stories about Rewalk Robotics (NASDAQ:RWLK) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Rewalk Robotics earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media stories about the medical device company an impact score of 46.4128674415072 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Shares of Rewalk Robotics (NASDAQ:RWLK) opened at $1.05 on Tuesday. The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02. Rewalk Robotics has a 12-month low of $1.05 and a 12-month high of $3.20. The company has a market capitalization of $30.37, a P/E ratio of -0.66 and a beta of 0.83.
A number of research firms have recently commented on RWLK. ValuEngine upgraded Rewalk Robotics from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd. Piper Jaffray Companies restated a “buy” rating and issued a $3.00 price objective on shares of Rewalk Robotics in a research report on Sunday, January 7th. Zacks Investment Research cut Rewalk Robotics from a “buy” rating to a “hold” rating in a research report on Thursday, January 4th. Oppenheimer set a $3.00 price objective on Rewalk Robotics and gave the company a “buy” rating in a research report on Monday, January 1st. Finally, Canaccord Genuity restated a “buy” rating and issued a $3.00 price objective on shares of Rewalk Robotics in a research report on Monday, November 6th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $2.83.
TRADEMARK VIOLATION NOTICE: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/13/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-rewalk-robotics-rwlk-share-price.html.
Rewalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.